Is Jiangsu Hengrui Medicine stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Jiangsu Hengrui Medicine pays dividends. Last time was Friday 12th of July 2024 where the investors holding the stock on Friday 12th of July 2024 were paid CNY0.2 per share. Over the last 24 times between 2001 and 2024, Jiangsu Hengrui Medicine has paid CNY3.25227 with an average of CNY0.14 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Jiangsu Hengrui Medicine 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was CNY57.37, you would have made a loss of CNY-6.58 per share or -11.47%
Yes, the average daily trading liquidity for Jiangsu Hengrui Medicine is CNY32.24 million. You should therefore be able to get in and out of your positions relatively fast.
Jiangsu Hengrui Medicine has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 16.05, the company's ability to pay off the debt is good. Jiangsu Hengrui Medicine has a very good net profit margin of 21.54% and should have very high tolerances against inflation.
We have calculated the inflation risk for Jiangsu Hengrui Medicine to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.